Rheumatoid arthritis is a progressive and debilitating autoimmune disease. It occurs when a person’s immune system becomes compromised causing inflammation and deterioration in the health of joints. Recurrent trips to the rheumatologist for those suffering from chronic RA. There are 2.4 million people in the United States that have RA; of those, more than 1 million have moderate to severe RA. According to the recent RAPP (Rheumatoid Arthritis Practice Performance) project assessment, fully 66% of patients with moderate to severe indications were not being seen in the prescribed treatment window due to scheduling and overloaded physician time.
As someone suffers from rheumatoid arthritis (RA), you may feel at a loss about ways to treat your condition. If so, you have much in common with the more than 2.4 million people in the U.S. would also have RA. These unfortunate experiences range from an inability to predict joint flare-ups to using therapies whose effects rapidly wear off over time, don’t work, or come with unpleasant side effects. These are dynamics we aim to help change.
Our landmark BRAVO (Baseline Rheumatoid Arthritis Verification Outcomes) study is a significant step towards producing the answers you need to manage and ultimately cure your RA. The BRAVO study will broadly assess over time the genomic changes of chronic RA sufferers who are currently using a range of therapies. The genomic patterns that emerge will eventually enable us to understand and predict which therapy is right for you and monitor and predict your disease activity.Participating in the study is easy. Use our sample collection kit to submit a finger-prick of blood that will yield the information we need to better understand your RA.